Combination therapy with antibody-drug conjugates
US8470329B2 · kind B2 · utility
20Cited by
8References
20Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Aug 13, 2012 |
| Grant date | Jun 25, 2013 |
| Priority date | — |
| Expiry date | Aug 13, 2032 |
Classification
- Technology area (CPC A)Human Necessities
- CPC primaryA61P43/00
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
Methods for the treatment of Hodgkin's lymphoma comprising administering both a chemotherapeutic regimen and an antibody-drug conjugate compound to a subject in need thereof are provided.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.